Alibaba Health Information Tech stock
Price history
−55.15% over the period1 year: from $5.83 (November 20, 2025) to $2.62 (November 20, 2026), −55.15%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | $2.62 |
| October 30, 2026 | $2.83 |
| September 30, 2026 | $2.87 |
| August 31, 2026 | $3.09 |
| July 31, 2026 | $3.59 |
| June 30, 2026 | $3.08 |
| May 29, 2026 | $3.63 |
| April 30, 2026 | $4.37 |
| March 31, 2026 | $4.66 |
| February 27, 2026 | $5.58 |
| January 30, 2026 | $6.52 |
| December 31, 2025 | $5.06 |
| November 28, 2025 | $5.57 |
| November 20, 2025 | $5.83 |
At a glance
The company
Operates an integrated online and offline healthcare platform offering pharmaceuticals, medical devices, and digital health services across China
Latest results
Quarter to September 30, 2025 · EPS ¥0.08 (estimate ¥0.06)
Next event
TickerLandia's take on Alibaba Health Information Tech
- Pricier than similar companies: trailing 12-month P/E 20 vs 17 (+17%) in a group of 8.
- Strong point: Financial strength (98/100 in its group). Weak point: Market momentum (17/100).
- “Dividend traps” (Hong Kong): No. 2 of 5.
- “Beaten down but solid” (Hong Kong): No. 4 of 28.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−66.94% from the 52-week high
Analysts · 15 analysts
Average target$4.43+69.36% vs. price
Buy 10 · Hold 3 · Sell 2
TickerLandia Fingerprint: Alibaba Health Information Tech
Compared with similar companies: very high financial strength, very weak momentum, and very low earnings stability.
Financials and price compared with 130 companies in related industries (retail), worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Priceaverage51
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 20.1 51 EV/EBITDA 17.2 73 Price/sales 1.23 57 Forward P/E 14.2 41 Price/book 2.01 33 Profitabilitylow38
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 24.0% 24 Operating margin 5.3% 35 Net margin 5.7% 58 ROE 11.3% 30 ROA 5.2% 42 Earnings stabilityvery low18
How steady its margins were over the last five annual reports.
Metric Value Position in group Loss-making yearscounts in reverse: lower means more earnings stability 1 of 5 annual reports 18 Margin variabilitycounts in reverse: lower means more earnings stability 4.3% 17 Growthaverage53
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +7.60% 58 Earnings growth (year over year) +0.70% 38 Average revenue growth (3 years) +8.58% 63 Financial strengthvery high98
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 1,304.3 100 Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −2.89 98 Debt/equitycounts in reverse: lower means more financial strength 0.00 99 Current ratio 3.03 94 Dividendaverage54
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 1 year 8 Payout ratiopays out more than its earnings 173.0% 98 Dividend yield 2.7% 55 Market momentumvery weak17
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −8.02% 32 Relative strength (6 months) −23.45% 19 1-year return −55.15% 2 Distance from 200-day average −32.65% 17 Riskhigh70
How much the price swings.
Metric Value Position in group Volatility (60 days) 32.9% 40 Beta (1 year) 1.44 79 Maximum drawdown (12 months) 66.4% 91
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Alibaba Health Information Tech is pricier than similar companies
Alibaba Health Information Tech's P/E (trailing 12 months): 20.1, +17% against the median of a group of 8 similar companies (17.2).
Compared with 8 similar companies
| Metric | Alibaba Health Information Tech | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 20.1 | Middle | |
| Forward P/E | 14.2 | Middle | |
| Operating margin | 5.3% | Low | |
| ROE | 11.3% | Middle | |
| Debt/equity | 0.00 | Low |
Grey band: the middle half of the group; tick: the median; dot: Alibaba Health Information Tech. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥17.56B
Latest quarter · Q1 2026
Net income
¥669.53M
Latest quarter · Q1 2026
Quarterly net margin
3.8%
Latest quarter · Q1 2026
Numbers and valuation
Full valuation- Market cap
- $42.3B
- P/E
- 20.1
- EPS
- $0.13
- Volume
- 129.86M
- Daily trading
- €25.71M
- Dividend yield
- 8.60%
- Last ex-dividend on August 12, 2026
How Alibaba Health Information Tech is changing
All resultsRevenue grew 17.2% a year on average over the last 5 years
Operating margin rose from −0.2% to 5.3%
Free cash flow equal to 86% of net income
Returns
Alibaba Health Information Tech returns with dividends
$1,000 invested in Alibaba Health Information Tech 5 years ago, on November 22, 2021, would be worth $294 today: −70.58% in total, −21.73% per year. This is the price return only: dividends are excluded.
| Period | Alibaba Health Information Tech | Hang Seng | $1,000 becomes |
|---|---|---|---|
| 1 month | −14.26% | −6.10% | $857 |
| 6 months | −33.12% | −12.63% | $669 |
| Year to date | −48.32% | −12.56% | $517 |
| 1 year | −52.11% | −13.26% | $479 |
| 3 years | −44.36% | +26.06% | $556 |
| 5 years | −70.58% | −10.18% | $294 |
| 10 years | −35.43% | +0.24% | $646 |
Over the last 6 months it has done better than 8% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. Hang Seng: price only. Calculate your investment
The chart in detail
Alibaba Health Information Tech: technical analysis
Alibaba Health Information Tech is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 91.3% below its all-time closing high ($29.90, February 17, 2021).
- Trend
- Downward
- RSI (14 sessions)
- 33
- Between 30 and 70
- vs 200-session average
- −32.65%
Active signals
New 52-week low.
since November 18, 2026
Close below the low of the previous 55 sessions.
Support and resistance
Price areas where Alibaba Health Information Tech has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$3.17+21.10%3 touches, last on November 5, 2026
- Resistance$3.05+16.68%4 touches, last on October 21, 2026
- Resistance$2.76+5.35%3 touches, last on October 30, 2026
- Last price$2.62
- No support below: the price is near the lows of the year
Volatility and risk
Over the last year it has moved more than the Hang Seng.
- Beta (1 year) vs Hang Seng
- 1.44
- Volatility (60 sessions, annualised)
- 32.9%
- Largest fall in the last year
- −66.39%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Alibaba Health Information Tech: seasonality
Average monthly price change over 24 years
Over the last 24 years, the strongest month for Alibaba Health Information Tech has been January: +24.60% on average, positive in 13 years out of 24. The weakest has been August: −5.34% on average, positive in 8 years out of 24. November, the current month, has been positive in 12 years out of 23 (+11.53% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +24.60% | +0.69% | 13 of 24 |
| February | +5.10% | +4.17% | 14 of 24 |
| March | +3.36% | +1.36% | 13 of 24 |
| April | +2.10% | −2.04% | 10 of 24 |
| May | +8.00% | −4.39% | 9 of 24 |
| June | +1.13% | −4.19% | 10 of 24 |
| July | −1.36% | −1.24% | 9 of 24 |
| August | −5.34% | −5.54% | 8 of 24 |
| September | +0.62% | −5.48% | 8 of 24 |
| October | +0.63% | −1.23% | 11 of 24 |
| November | +11.53% | +6.90% | 12 of 23 |
| December | −0.39% | −2.68% | 9 of 24 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Alibaba Health Information Tech and its competitors
Based in Causeway Bay, Hong Kong, the group has existed since 1998, when it was incorporated under the name CITIC 21CN Company Limited, a name it changed in September 2014. Its activities cover pharmacy sales, both in physical outlets and online, of medicines, nutritional supplements, medical devices, contact lenses and health foods, alongside medical consultation, checkups, dental and vision services and traditional Chinese medicine. Customers include consumers and businesses, and the offering reaches buyers across the People's Republic of China via stores on platforms such as Tmall, Taobao and Alipay.
- Headquarters
- Causeway Bay, Hong Kong
- Employees
- 1,394
- Founded
- 1998
- Chief executive
- Yong Yu
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Alibaba Health Information Tech0241 | $5.4B | 5.3% | 20.1 | −33.12% |
| JD Health International6618 | $13.26B | 6.1% | 15.0 | −19.27% |
| Raia DrogasilRADL3 | $4.04B | 6.1% | 17.6 | −24.57% |
| Redcare PharmacyRDC | $1.47B | 0.3% | — | +36.52% |
| JB Hi-FiJBH | $5.49B | 6.6% | 16.8 | +8.17% |
| Tokyu9005 | $5.51B | 8.9% | 10.1 | −4.13% |
Same industry or related industries, similar size. Compare Alibaba Health Information Tech with its competitors · Full profile
More on Alibaba Health Information Tech
- Alibaba Health Information Tech revenue and financials
- Alibaba Health Information Tech dividend and valuation
- Alibaba Health Information Tech stock return
- Alibaba Health Information Tech employees, headquarters and business
